Table 1.

Clinical data for 15 children with steroid-resistant focal segmental glomerulosclerosis before and after IVCP therapy.

No.	Age at Onset (years)	Sex	Steroid Resistant	Glomerular sclerosis	Pathology		IgM	Time of IVCP response	1st relapse Post IVCP (months)	Final Outcome
					Interstitial fibrosis	Tubular atrophy
1	2	F	Late	16 %	Mild	None	Positive 3+	2nd dose	8	Dependent
2	2 1/2	M	Late	12 %	Mild	None	Negative	4th dose	7	Dependent
3	1 1/2	M	Initial	8 %	Moderate	Mild	Positive 3+	-	-	Resistant
4	2	M	Late	10 %	Mild	Mild	Negative	3rd dose	Dependent	Dependent
5	1 1/2	F	Initial	25 %	Mild	Mild	Negative	-	-	Resistant (CRF)
6		M	Initial	13 %	Mild	None	Negative	-	-	Resistant
7	5	M	Late	27 %	Moderate	Moderate	Positive 2+	4th dose	12	Dependent
8	2 1/2	M	Late	10 %	Mild	None	Positive 2+	3rd dose	Dependent	Dependent
9	3	M	Late	5 %	Mild	None	Positive 3+	2nd dose	Dependent	Dependent
10	1 1/2	M	Late	4 %	Moderate	None	Negative	2nd dose	24	Dependent
11	6	F	Late	9 %	Mild	None	Positive 3+	2nd dose	Dependent	Dependent
12	8	M	Initial	14 %	Mild	Mild	Positive 2+	-	-	Resistant (CRF)
13	1 1/2	M	Late	12 %	Mild	None	Negative	4th dose	Dependent	Dependent
14	1	F	Initial	8 %	Mild	None	Negative	-	-	Resistant (CRF)
15	3	F	Late	14 %	Mild	None	Negative	3rd dose	12	Dependent